194 related articles for article (PubMed ID: 17971213)
1. The E5 protein of the human papillomavirus type 16 down-regulates HLA-I surface expression in calnexin-expressing but not in calnexin-deficient cells.
Gruener M; Bravo IG; Momburg F; Alonso A; Tomakidi P
Virol J; 2007 Oct; 4():116. PubMed ID: 17971213
[TBL] [Abstract][Full Text] [Related]
2. E5 protein of human papillomavirus 16 downregulates HLA class I and interacts with the heavy chain via its first hydrophobic domain.
Ashrafi GH; Haghshenas M; Marchetti B; Campo MS
Int J Cancer; 2006 Nov; 119(9):2105-12. PubMed ID: 16823848
[TBL] [Abstract][Full Text] [Related]
3. All 4 di-leucine motifs in the first hydrophobic domain of the E5 oncoprotein of human papillomavirus type 16 are essential for surface MHC class I downregulation activity and E5 endomembrane localization.
Cortese MS; Ashrafi GH; Campo MS
Int J Cancer; 2010 Apr; 126(7):1675-82. PubMed ID: 19876920
[TBL] [Abstract][Full Text] [Related]
4. E5 protein of human papillomavirus type 16 selectively downregulates surface HLA class I.
Ashrafi GH; Haghshenas MR; Marchetti B; O'Brien PM; Campo MS
Int J Cancer; 2005 Jan; 113(2):276-83. PubMed ID: 15386416
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of MHC class I is a property common to papillomavirus E5 proteins.
Ashrafi GH; Brown DR; Fife KH; Campo MS
Virus Res; 2006 Sep; 120(1-2):208-11. PubMed ID: 16780984
[TBL] [Abstract][Full Text] [Related]
6. The first hydrophobic region of the HPV16 E5 protein determines protein cellular location and facilitates anchorage-independent growth.
Lewis C; Baro MF; Marques M; Grüner M; Alonso A; Bravo IG
Virol J; 2008 Feb; 5():30. PubMed ID: 18302753
[TBL] [Abstract][Full Text] [Related]
7. HPV-16 E5 down-regulates expression of surface HLA class I and reduces recognition by CD8 T cells.
Campo MS; Graham SV; Cortese MS; Ashrafi GH; Araibi EH; Dornan ES; Miners K; Nunes C; Man S
Virology; 2010 Nov; 407(1):137-42. PubMed ID: 20813390
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of MHC class I by bovine papillomavirus E5 oncoproteins.
Ashrafi GH; Tsirimonaki E; Marchetti B; O'Brien PM; Sibbet GJ; Andrew L; Campo MS
Oncogene; 2002 Jan; 21(2):248-59. PubMed ID: 11803468
[TBL] [Abstract][Full Text] [Related]
9. The E5 oncoprotein of BPV-4 does not interfere with the biosynthetic pathway of non-classical MHC class I.
Araibi EH; Marchetti B; Dornan ES; Ashrafi GH; Dobromylskyj M; Ellis SA; Campo MS
Virology; 2006 Sep; 353(1):174-83. PubMed ID: 16806386
[TBL] [Abstract][Full Text] [Related]
10. The human papillomavirus type 16 E5 oncoprotein synergizes with EGF-receptor signaling to enhance cell cycle progression and the down-regulation of p27(Kip1).
Pedroza-Saavedra A; Lam EW; Esquivel-Guadarrama F; Gutierrez-Xicotencatl L
Virology; 2010 Apr; 400(1):44-52. PubMed ID: 20144468
[TBL] [Abstract][Full Text] [Related]
11. The human papillomavirus HPV2a E5 protein localizes to the Golgi apparatus and modulates signal transduction.
Cartin W; Alonso A
Virology; 2003 Sep; 314(2):572-9. PubMed ID: 14554085
[TBL] [Abstract][Full Text] [Related]
12. CD1d, a sentinel molecule bridging innate and adaptive immunity, is downregulated by the human papillomavirus (HPV) E5 protein: a possible mechanism for immune evasion by HPV.
Miura S; Kawana K; Schust DJ; Fujii T; Yokoyama T; Iwasawa Y; Nagamatsu T; Adachi K; Tomio A; Tomio K; Kojima S; Yasugi T; Kozuma S; Taketani Y
J Virol; 2010 Nov; 84(22):11614-23. PubMed ID: 20810727
[TBL] [Abstract][Full Text] [Related]
13. HPV16 E5 Mediates Resistance to PD-L1 Blockade and Can Be Targeted with Rimantadine in Head and Neck Cancer.
Miyauchi S; Sanders PD; Guram K; Kim SS; Paolini F; Venuti A; Cohen EEW; Gutkind JS; Califano JA; Sharabi AB
Cancer Res; 2020 Feb; 80(4):732-746. PubMed ID: 31848196
[TBL] [Abstract][Full Text] [Related]
14. The E5 protein of human papillomavirus type 16 perturbs MHC class II antigen maturation in human foreskin keratinocytes treated with interferon-gamma.
Zhang B; Li P; Wang E; Brahmi Z; Dunn KW; Blum JS; Roman A
Virology; 2003 May; 310(1):100-8. PubMed ID: 12788634
[TBL] [Abstract][Full Text] [Related]
15. The E5 protein of BPV-4 interacts with the heavy chain of MHC class I and irreversibly retains the MHC complex in the Golgi apparatus.
Marchetti B; Ashrafi GH; Dornan ES; Araibi EH; Ellis SA; Campo MS
Oncogene; 2006 Apr; 25(15):2254-63. PubMed ID: 16288210
[TBL] [Abstract][Full Text] [Related]
16. The bovine papillomavirus oncoprotein E5 retains MHC class I molecules in the Golgi apparatus and prevents their transport to the cell surface.
Marchetti B; Ashrafi GH; Tsirimonaki E; O'Brien PM; Campo MS
Oncogene; 2002 Nov; 21(51):7808-16. PubMed ID: 12420217
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the plasma membrane localization and orientation of HPV16 E5 for cell-cell fusion.
Hu L; Ceresa BP
Virology; 2009 Oct; 393(1):135-43. PubMed ID: 19712955
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus type 16 E5 protein induces expression of beta interferon through interferon regulatory factor 1 in human keratinocytes.
Muto V; Stellacci E; Lamberti AG; Perrotti E; Carrabba A; Matera G; Sgarbanti M; Battistini A; Liberto MC; Focà A
J Virol; 2011 May; 85(10):5070-80. PubMed ID: 21389130
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic T-lymphocyte responses to human papillomavirus type 16 E5 and E7 proteins and HLA-A*0201-restricted T-cell peptides in cervical cancer patients.
Liu DW; Yang YC; Lin HF; Lin MF; Cheng YW; Chu CC; Tsao YP; Chen SL
J Virol; 2007 Mar; 81(6):2869-79. PubMed ID: 17202211
[TBL] [Abstract][Full Text] [Related]
20. The HPV16 E5 protein: expression, detection, and stable complex formation with transmembrane proteins in COS cells.
Hwang ES; Nottoli T; Dimaio D
Virology; 1995 Aug; 211(1):227-33. PubMed ID: 7645215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
